Company Filing History:
Years Active: 2007
Title: Kyri Dunussi: Innovator in Immune Modulation
Introduction
Kyri Dunussi is a notable inventor based in Belmont, MA (US). He has made significant contributions to the field of immunology through his innovative research and patent work. His expertise lies in the modulation of interleukin-21 receptor activity, which has important implications for treating various immune-related conditions.
Latest Patents
Kyri Dunussi holds a patent for "Methods and compositions for modulating interleukin-21 receptor activity." This patent describes methods and compositions that utilize agonists or antagonists of interleukin-21 (IL-21) or its receptor (IL-21R) to modulate immune responses. The patent outlines how IL-21/IL-21R antagonists can induce immune suppression in vivo, which may be beneficial for treating or preventing immune cell-associated pathologies, such as transplant rejection and autoimmune disorders. Conversely, IL-21/IL-21R agonists can enhance immune responses, making them useful in cancer treatment and infectious disorders.
Career Highlights
Kyri Dunussi is associated with Genetics Institute, Inc., where he continues to advance his research in immunology. His work has led to a deeper understanding of immune modulation and its potential therapeutic applications. With a patent portfolio that includes one patent, he is recognized for his innovative contributions to the field.
Collaborations
Kyri collaborates with esteemed colleagues, including Laura L. Carter and Beatriz M. Carreno. These collaborations enhance the research efforts at Genetics Institute, Inc. and contribute to the advancement of immunological therapies.
Conclusion
Kyri Dunussi's work in modulating interleukin-21 receptor activity represents a significant advancement in immunology. His innovative approaches have the potential to lead to new treatments for various immune-related conditions.